Movement Disorders and Therapeutic Applications of Botulinum Toxin
A special issue of Toxins (ISSN 2072-6651). This special issue belongs to the section "Bacterial Toxins".
Deadline for manuscript submissions: closed (31 December 2020) | Viewed by 7671
Special Issue Editors
Special Issue Information
Dear Colleagues,
Movement disorders were among the earliest therapeutic uses of botulinum toxin. There is now over 30 years’ experience with botulinum toxin treatment of dystonic disorders, including blepharospasm, cervical dystonia, and focal had dystonia, as well as other neurologic conditions, such as hemifacial spasm, tremor, and spasticity. The use of BoNT for neurosecretory disorders has expanded, including the treatment of sialorrhea which is often seen in association with a movement disorder. A number of these conditions lack other effective treatments, making botulinum toxin a first-line therapy. The number of applications continues to evolve along with increasing understanding of botulinum toxin’s physiologic effects centrally and peripherally and its mechanism of action in treating movement disorders. The methodology of administering botulinum toxin is similarly progressing.
This Special Issue will focus on the current status of botulinum toxin for the treatment of movement disorders (encompassing focal, generalized and secondary dystonias, tremor, ataxia, tics, and chorea), sialorrhea, as well as technical approaches to botulinum toxin usage, including issues such as dosing, guidance techniques, and target muscle selection.
Dr. Barbara I. Karp
Dr. Katharine Alter
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Toxins is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- botulinum toxin
- dystonia
- spasticity
- cervical dystonia
- focal hand dystonia
- tics
- tremor
- onabotulinumtoxinA
- abobotulinumtoxinA
- incobotulinumtoxinA
- rimabotulinumtoxinB
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
